![Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast Cancer | JCO Precision Oncology Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast Cancer | JCO Precision Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/po/2020/po.2020.4/po.20.00117/20201015/images/large/po.20.00117t2.jpeg)
Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast Cancer | JCO Precision Oncology
![SciELO - Brasil - Avaliação dos valores sérico e pleural dos marcadores tumorais CEA, CYFRA21-1 e CA 15-3 em portadores de derrame pleural Avaliação dos valores sérico e pleural dos marcadores tumorais SciELO - Brasil - Avaliação dos valores sérico e pleural dos marcadores tumorais CEA, CYFRA21-1 e CA 15-3 em portadores de derrame pleural Avaliação dos valores sérico e pleural dos marcadores tumorais](https://minio.scielo.br/documentstore/1806-3756/nQjvwNHDS5FfkVyXSjRgDNm/70d0adfa6d4e45227c91efe0c3490ba423853b79.gif)
SciELO - Brasil - Avaliação dos valores sérico e pleural dos marcadores tumorais CEA, CYFRA21-1 e CA 15-3 em portadores de derrame pleural Avaliação dos valores sérico e pleural dos marcadores tumorais
Diagnostic significance of the tumour markers CEA, CA 15–3 and CA 125 in malignant effusions in breast cancer
![Jornal Brasileiro de Pneumologia - Avaliação dos valores sérico e pleural dos marcadores tumorais CEA, CYFRA21-1 e CA 15-3 em portadores de derrame pleural Jornal Brasileiro de Pneumologia - Avaliação dos valores sérico e pleural dos marcadores tumorais CEA, CYFRA21-1 e CA 15-3 em portadores de derrame pleural](https://cdn.publisher.gn1.link/jornaldepneumologia.com.br/414_13table4.gif)
Jornal Brasileiro de Pneumologia - Avaliação dos valores sérico e pleural dos marcadores tumorais CEA, CYFRA21-1 e CA 15-3 em portadores de derrame pleural
![Survival curves for patients with CA 15-3 >30 kU/l and no metastasis at... | Download Scientific Diagram Survival curves for patients with CA 15-3 >30 kU/l and no metastasis at... | Download Scientific Diagram](https://www.researchgate.net/publication/24213426/figure/fig1/AS:460229222637571@1486738605171/Survival-curves-for-patients-with-CA-15-3-30-kU-l-and-no-metastasis-at-diagnosis-M2-as.png)
Survival curves for patients with CA 15-3 >30 kU/l and no metastasis at... | Download Scientific Diagram
![Serum tumor markers in advanced stages of chronic kidney diseases Rani B S, Suchitra M M, Srinivasa Rao P, Kumar V S - Saudi J Kidney Dis Transpl Serum tumor markers in advanced stages of chronic kidney diseases Rani B S, Suchitra M M, Srinivasa Rao P, Kumar V S - Saudi J Kidney Dis Transpl](https://www.sjkdt.org/articles/2019/30/4/images/SaudiJKidneyDisTranspl_2019_30_4_898_265466_t3.jpg)
Serum tumor markers in advanced stages of chronic kidney diseases Rani B S, Suchitra M M, Srinivasa Rao P, Kumar V S - Saudi J Kidney Dis Transpl
![CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-14-356/MediaObjects/12885_2013_Article_4542_Fig2_HTML.jpg)
CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text
![Serum tumor markers in advanced stages of chronic kidney diseases Rani B S, Suchitra M M, Srinivasa Rao P, Kumar V S - Saudi J Kidney Dis Transpl Serum tumor markers in advanced stages of chronic kidney diseases Rani B S, Suchitra M M, Srinivasa Rao P, Kumar V S - Saudi J Kidney Dis Transpl](https://www.sjkdt.org/articles/2019/30/4/images/SaudiJKidneyDisTranspl_2019_30_4_898_265466_t2.jpg)
Serum tumor markers in advanced stages of chronic kidney diseases Rani B S, Suchitra M M, Srinivasa Rao P, Kumar V S - Saudi J Kidney Dis Transpl
![Frontiers | Established Tumour Biomarkers Predict Cardiovascular Events and Mortality in the General Population Frontiers | Established Tumour Biomarkers Predict Cardiovascular Events and Mortality in the General Population](https://www.frontiersin.org/files/Articles/753885/fcvm-08-753885-HTML/image_m/fcvm-08-753885-t005.jpg)
Frontiers | Established Tumour Biomarkers Predict Cardiovascular Events and Mortality in the General Population
![CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-14-356/MediaObjects/12885_2013_Article_4542_Fig1_HTML.jpg)
CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text
![Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer - ESMO Open Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer - ESMO Open](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1010e8b5-057f-4565-93f0-d6884917ae40/gr1_lrg.jpg)